Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-03-17
1999-01-05
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5462727, A61K 3144
Patent
active
058563431
ABSTRACT:
Compounds of formula I, ##STR1## wherein R.sub.1 to R.sub.4 possess the significances given in the description, may be used in the treatment of senile dementia, Alzheimer's disease and depression.
REFERENCES:
patent: 3417091 (1968-12-01), Pickholz et al.
patent: 3993643 (1976-11-01), Henry et al.
patent: 4230714 (1980-10-01), Cross et al.
patent: 4404387 (1983-09-01), Gall
patent: 4591377 (1986-05-01), Leone-Bay et al.
patent: 4634711 (1987-01-01), Kaiser et al.
patent: 4659720 (1987-04-01), Chabala et al.
patent: 4925851 (1990-05-01), Houlihan
patent: 4937250 (1990-06-01), Bowman et al.
patent: 5021434 (1991-06-01), Strehlke et al.
Shutske Medicinal Chemistry Approaches To A.D and Other Dementias Symposium, Division of Educational Services, Mayo Clinic, 1993.
Annals, vol. 643, pp. 136-144 (1961).
J. Heterocyclic Chem., vol. 14, pp. 1279-1281 (1977).
Inorg. Chem., vol. 16, No. 6, pp. 1470-1476 (1977).
Derwent Abstract 86-140808.
Derwent Abstract 88-358545.
Derwent Abstract 90-096560.
Derwent Abstract 90-301291.
Borovian Joseph J.
Fan Jane
Novartis AG
LandOfFree
Imidazolylmethyl-pyridines used for senile dementia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolylmethyl-pyridines used for senile dementia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolylmethyl-pyridines used for senile dementia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-862636